Zevra Therapeutics (ZVRA) Other Accumulated Expenses (2015 - 2026)
Zevra Therapeutics' Other Accumulated Expenses was $1.32 million in Q3 2026, down 85.4% from $8.99 million a year earlier and down 7.5% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Other Accumulated Expenses (2015 - 2026) Analysis & Trends
At the end of FY2025, Other Accumulated Expenses at Zevra Therapeutics came in at $1.36 million, down 39.7% from FY2024.
- Other Accumulated Expenses shows a five-year compound annual growth rate of 16.9% (FY2020 to FY2025).
- In earlier years, Other Accumulated Expenses was $2.26 million in FY2024 (-26.4%), $3.07 million in FY2023 (+327.0%), $719,000 in FY2022 (-14.0%) and $836,000 in FY2021 (+34.0%).
- The Q3 2026 figure marks the lowest quarterly Other Accumulated Expenses since Q3 2024.
- Compared with a year earlier, Other Accumulated Expenses has declined for four straight quarters, with growth averaging 100.1% over the last eight quarters.
- The best year-over-year quarter for Other Accumulated Expenses over five years was Q3 2025 (growth of 866.7%); the worst was Q1 2022 (a decline of 98.1%).
- Per Business Quant data, ZVRA's Other Accumulated Expenses in the three quarters before Q3 2026 was $1.42 million (Q2 2026), $1.41 million (Q1 2026) and $1.36 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.32 Mn |
| Jun 30, 2026 | 1.42 Mn |
| Mar 31, 2026 | 1.41 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | 8.99 Mn |
| Jun 30, 2025 | 6.87 Mn |
| Mar 31, 2025 | 3.40 Mn |
| Dec 31, 2024 | 2.26 Mn |
| Sep 30, 2024 | 930,000.00 |
| Jun 30, 2024 | 2.63 Mn |
| Mar 31, 2024 | 2.09 Mn |
| Dec 31, 2023 | 3.07 Mn |
| Sep 30, 2023 | 311,000.00 |
| Jun 30, 2023 | 321,000.00 |
| Mar 31, 2023 | 302,000.00 |
| Dec 31, 2022 | 719,000.00 |
| Sep 30, 2022 | 853,000.00 |
| Jun 30, 2022 | 1.29 Mn |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 836,000.00 |
API Access
Zevra Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();